243 related articles for article (PubMed ID: 21688267)
1. Post-transcriptional regulation of the Ras-ERK/MAPK signaling pathway.
Whelan JT; Hollis SE; Cha DS; Asch AS; Lee MH
J Cell Physiol; 2012 Mar; 227(3):1235-41. PubMed ID: 21688267
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
Roberts PJ; Der CJ
Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
[TBL] [Abstract][Full Text] [Related]
3. Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.
Sasaki A; Taketomi T; Kato R; Saeki K; Nonami A; Sasaki M; Kuriyama M; Saito N; Shibuya M; Yoshimura A
Nat Cell Biol; 2003 May; 5(5):427-32. PubMed ID: 12717443
[TBL] [Abstract][Full Text] [Related]
4. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
5. Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation.
Hecquet C; Lefevre G; Valtink M; Engelmann K; Mascarelli F
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3091-8. PubMed ID: 12202534
[TBL] [Abstract][Full Text] [Related]
6. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
Yang R; Piperdi S; Gorlick R
Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus E2 protein promotes human hepatoma cell proliferation through the MAPK/ERK signaling pathway via cellular receptors.
Zhao LJ; Wang L; Ren H; Cao J; Li L; Ke JS; Qi ZT
Exp Cell Res; 2005 Apr; 305(1):23-32. PubMed ID: 15777784
[TBL] [Abstract][Full Text] [Related]
8. APC inhibits ERK pathway activation and cellular proliferation induced by RAS.
Park KS; Jeon SH; Kim SE; Bahk YY; Holmen SL; Williams BO; Chung KC; Surh YJ; Choi KY
J Cell Sci; 2006 Mar; 119(Pt 5):819-27. PubMed ID: 16478791
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction.
Elowe S; Holland SJ; Kulkarni S; Pawson T
Mol Cell Biol; 2001 Nov; 21(21):7429-41. PubMed ID: 11585923
[TBL] [Abstract][Full Text] [Related]
10. K-Ras gene status and expression of Ras/mitogen-activated protein kinase (MAPK) signaling molecules in ameloblastomas.
Kumamoto H; Takahashi N; Ooya K
J Oral Pathol Med; 2004 Jul; 33(6):360-7. PubMed ID: 15200485
[TBL] [Abstract][Full Text] [Related]
11. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
[TBL] [Abstract][Full Text] [Related]
12. Coordinating ERK/MAPK signalling through scaffolds and inhibitors.
Kolch W
Nat Rev Mol Cell Biol; 2005 Nov; 6(11):827-37. PubMed ID: 16227978
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review).
Chang F; Steelman LS; Shelton JG; Lee JT; Navolanic PM; Blalock WL; Franklin R; McCubrey JA
Int J Oncol; 2003 Mar; 22(3):469-80. PubMed ID: 12579299
[TBL] [Abstract][Full Text] [Related]
14. Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy.
Friday BB; Adjei AA
Clin Cancer Res; 2008 Jan; 14(2):342-6. PubMed ID: 18223206
[TBL] [Abstract][Full Text] [Related]
15. Hyperactive Ras in developmental disorders and cancer.
Schubbert S; Shannon K; Bollag G
Nat Rev Cancer; 2007 Apr; 7(4):295-308. PubMed ID: 17384584
[TBL] [Abstract][Full Text] [Related]
16. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells.
Kim MS; Lee EJ; Kim HR; Moon A
Cancer Res; 2003 Sep; 63(17):5454-61. PubMed ID: 14500381
[TBL] [Abstract][Full Text] [Related]
17. Development and implementation of three mitogen-activated protein kinase (MAPK) signaling pathway imaging assays to provide MAPK module selectivity profiling for kinase inhibitors: MK2-EGFP translocation, c-Jun, and ERK activation.
Nickischer D; Laethem C; Trask OJ; Williams RG; Kandasamy R; Johnston PA; Johnston PA
Methods Enzymol; 2006; 414():389-418. PubMed ID: 17110204
[TBL] [Abstract][Full Text] [Related]
18. [The role of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance of hepatocellular carcinoma].
Zhu H; Chen XP; Luo SF; Guan J; Zhang WG; Zhang BX; Mao CP
Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):917-20. PubMed ID: 17953842
[TBL] [Abstract][Full Text] [Related]
19. Role of lipids in the MAPK signaling pathway.
Anderson DH
Prog Lipid Res; 2006 Mar; 45(2):102-19. PubMed ID: 16455141
[TBL] [Abstract][Full Text] [Related]
20. Sustained activation of M-Ras induced by nerve growth factor is essential for neuronal differentiation of PC12 cells.
Sun P; Watanabe H; Takano K; Yokoyama T; Fujisawa J; Endo T
Genes Cells; 2006 Sep; 11(9):1097-113. PubMed ID: 16923128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
